Freya Van Hulle
Overview
Explore the profile of Freya Van Hulle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Paep D, Van Hulle F, Ling Z, Vanhoeij M, Hilbrands R, Distelmans W, et al.
Cell Transplant
. 2022 May;
31:9636897221096160.
PMID: 35583214
Patients fulfilling criteria for euthanasia can choose to donate their organs after circulatory death [donors after euthanasia (DCD V)]. This study assesses the outcome of islet cell isolation from DCD...
2.
Van Hulle F, De Groot K, Hilbrands R, Van de Velde U, Suenens K, Stange G, et al.
Am J Transplant
. 2021 Nov;
22(3):927-936.
PMID: 34735732
Intraportal (IP) islet cell transplants can restore metabolic control in type 1 diabetes patients, but limitations raise the need for establishing a functional beta cell mass (FBM) in a confined...
3.
Bonkain F, Stolear J, Catalano C, Vandervelde D, Treille S, Couttenye M, et al.
PLoS One
. 2021 May;
16(5):e0251793.
PMID: 34015014
Background: The efficacy and cost-effectiveness of prophylactic thrombolytic locks in hemodialysis patients at high-risk of thrombotic dialysis catheter dysfunction is uncertain. We investigated this question in a double-blinded randomized controlled...
4.
De Paep D, Van Hulle F, Ling Z, Vanhoeij M, Pirenne J, Keymeulen B, et al.
PLoS One
. 2021 May;
16(5):e0251055.
PMID: 33939760
Organs from donors after controlled circulatory death (DCD III) exhibit a higher risk for graft dysfunction due to an initial period of warm ischemia. This procurement condition can also affect...
5.
Van Hulle F, De Groot K, Stange G, Suenens K, De Mesmaeker I, De Paep D, et al.
Am J Transplant
. 2020 Nov;
21(6):2090-2099.
PMID: 33206461
Detection of amyloid in intraportal islet implants of type 1 diabetes patients has been proposed as cause in their functional decline. The present study uses cultured adult human islets devoid...
6.
De Mesmaeker I, Robert T, Suenens K, Stange G, Van Hulle F, Ling Z, et al.
Diabetes
. 2018 Oct;
67(12):2640-2649.
PMID: 30305364
Alginate (Alg)-encapsulated porcine islet cell grafts are developed to overcome limitations of human islet transplantation. They can generate functional implants in animals when prepared from fetal, perinatal, and adult pancreases....
7.
Van Hulle F, Bonkain F, De Clerck D, Aerden D, Vanwijn I, Tielemans C, et al.
J Vasc Access
. 2018 Jun;
20(1):60-69.
PMID: 29893163
Background:: There are few data to inform decisions about the optimal management of occluded tunneled cuffed hemodialysis catheters with thrombolytic locking solutions. The effect of dose, dwell-time, and number of...
8.
Pipeleers D, De Mesmaeker I, Robert T, Van Hulle F
Curr Diab Rep
. 2017 Aug;
17(10):86.
PMID: 28812213
Purpose Of Review: Intercellular differences in function have since long been noticed in the pancreatic beta-cell population. Heterogeneity in cellular glucose responsiveness is considered of physiological and pathological relevance. The...
9.
Bonkain F, Van Hulle F, Janssens P, Catalano C, Allamani M, Stolear J, et al.
J Vasc Access
. 2017 Jun;
18(5):436-442.
PMID: 28623638
Introduction: The prophylactic use of recombinant tissue plasminogen activator once weekly reduces the incidence rate of tunneled cuffed catheter (TCC) malfunction and bacteremia as compared to the exclusive use of...